What a disastrous day for news!
MTFB:Motif Bio had its new drug application for Iclaprim turned down by the FDA because they require the application to "further evaluate the risk for liver toxicity".
The share price crashed 73% and my holding with around £500 paper profit now has paper loss of £1,704.
Aaaaarrrrghhhh!!!!!!
The only ray of sunshine is that I sold 25% of my holding on Monday to buy some CWR:Ceres Power shares.
I was sulking all day about that, but came home to an RNS from KIBO:Kibo Energy to say that TANESCO have rejected their Power Purchase Agreement application, saying Kibo "did not qualify to compete in the next stage of the bidding process" but giving absolutely no reason.
KIBO:Kibo Energy shares crashed 50% as a result, so my holding is now down 89% with paper loss of £2,343.
Meanwhile OPT:Optibiotix slipped another 3p which cost me £2,400
Absolutely bloody horrible
The combined portfolios hover on the very cusp, being just £27 in the black
The week had been so wonderful up to today - now it's all gone to hell in a handcart.
I'm no longer looking forward to writing tomorrow's review and I'm off to the pub to drown my sorrows!
No comments:
Post a Comment